Virtu Financial
SBFM icon

Virtu Financial’s Sunshine Biopharma SBFM Stock Holding History

Virtu Financial’s Portfolio SBFM Stock Details SBFM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-117
Closed -$29K – 2221
2025
Q4 		$29K Buy
+117
New +$37K ﹤0.01% 1370
2024
Q1 		– Hold
0
– -$6K – 2013
2023
Q4 		– Hold
0
– – – 1459
2023
Q2 		– Hold
0
– -$20K – 1970
2023
Q1 		– Hold
0
– – – 1243
2022
Q4 		– Hold
0
– – – 1240
2022
Q3 		– Hold
0
– -$52K – 2173
2022
Q2 		– Hold
0
– – – 1117
2022
Q1 		– Hold
0
– – – 1216

Other funds holding SBFM

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
XTX Topco
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Virtu Financial's SBFM Position: Q1 2026 in Review

Virtu Financial sold out of Sunshine Biopharma (SBFM) in Q1 2026, closing a stake of 117 shares — an estimated $29K sold.

Virtu Financial first reported a position in SBFM in Q4 2025 and held it in 1 quarter. The position peaked at $29K in Q4 2025. 7 funds tracked by Wall St. Rank hold SBFM as of Q1 2026.

  • Virtu Financial reported no remaining Sunshine Biopharma position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 117 Sunshine Biopharma shares in Q1 2026, an estimated $29K.
  • Virtu Financial first reported a position in Sunshine Biopharma in Q4 2025 and held it in 1 quarter.
  • Virtu Financial's Sunshine Biopharma position peaked at $29K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.